open access

Vol 15, No 1 (2021)
Research paper
Published online: 2021-01-13
Get Citation

Health care services utilization and cost in the last year of life in Colombia: a retrospective study

Emilio Herrera Molina12, Yaneth Marcela Montoya Jaramillo3, Zacarías Rodriguez Álvarez-Ossorio1, Ana Carolina Gñomez García1, Miguel Ángel Lucas Díaz1, Irma María Echeverri Rincón3, Ingrid Muñoz Mayorga1, María Nabal Vicuña4
·
Palliat Med Pract 2021;15(1):9-17.
Affiliations
  1. New Health Foundation., Menendez Pelayo Av, 20. 4º, 41004 Sevilla, Spain
  2. Keralty, Miami, United States
  3. EPS and Medicina prepagada Suramericana SA., Medellín, Colombia
  4. Palliative care team. Arnau de Villanova Hospital., Lleida, Spain

open access

Vol 15, No 1 (2021)
Research paper
Published online: 2021-01-13

Abstract

Introduction: Health care costs at the end of life cause a high expenditure on health care resources. The
implementation of integrated palliative care programs has proven to be cost-efficient. The study aimed
to analyze the consumption and cost of health care resources during the last year of life of patients who
are not part of a palliative care program.
Methods: A descriptive, longitudinal and retrospective study was conducted in patients of a Colombian health
insurance company who died in 2013 due to pathologies that were susceptible and non-susceptible
to palliative care. Causes of death were obtained from official death certificates. McNamara et al. strategy
of classification was applied and adapted to assess services received during the last year of life. Analysis
of costs was conducted by pathologies at different levels of care.
Results: 3,392 deaths in 2013 (70% susceptible to palliative care and 30% non-susceptible to palliative
care). Total health care cost: USD 47,550,155. Patients susceptible to palliative care were responsible for
84% of the year’s expenditure (the annual expenditure) (USD 40 million). There were significant differences
between the average costs for susceptible and non-susceptible palliative care patients (USD 16,878 versus
USD 7,433 per year, p < 0.001). The average cost per patient for the last three months of life represented
52% of the expenditure during the last year of life (USD 8,754). The last month of life was 25.6% of the
expenditure during the last year of life (USD 4,324).
Conclusions: Cost of care for the last three months of life of susceptible palliative care patients generates
a huge health care expenditure, mainly attributable to hospital care cost. The implementation of a palliative
care program could decrease these assistance costs.

Abstract

Introduction: Health care costs at the end of life cause a high expenditure on health care resources. The
implementation of integrated palliative care programs has proven to be cost-efficient. The study aimed
to analyze the consumption and cost of health care resources during the last year of life of patients who
are not part of a palliative care program.
Methods: A descriptive, longitudinal and retrospective study was conducted in patients of a Colombian health
insurance company who died in 2013 due to pathologies that were susceptible and non-susceptible
to palliative care. Causes of death were obtained from official death certificates. McNamara et al. strategy
of classification was applied and adapted to assess services received during the last year of life. Analysis
of costs was conducted by pathologies at different levels of care.
Results: 3,392 deaths in 2013 (70% susceptible to palliative care and 30% non-susceptible to palliative
care). Total health care cost: USD 47,550,155. Patients susceptible to palliative care were responsible for
84% of the year’s expenditure (the annual expenditure) (USD 40 million). There were significant differences
between the average costs for susceptible and non-susceptible palliative care patients (USD 16,878 versus
USD 7,433 per year, p < 0.001). The average cost per patient for the last three months of life represented
52% of the expenditure during the last year of life (USD 8,754). The last month of life was 25.6% of the
expenditure during the last year of life (USD 4,324).
Conclusions: Cost of care for the last three months of life of susceptible palliative care patients generates
a huge health care expenditure, mainly attributable to hospital care cost. The implementation of a palliative
care program could decrease these assistance costs.

Get Citation

Keywords

palliative care, cause of death, population, cost-benefits analysis, models

About this article
Title

Health care services utilization and cost in the last year of life in Colombia: a retrospective study

Journal

Palliative Medicine in Practice

Issue

Vol 15, No 1 (2021)

Article type

Research paper

Pages

9-17

Published online

2021-01-13

Page views

904

Article views/downloads

456

DOI

10.5603/PMPI.2021.0004

Bibliographic record

Palliat Med Pract 2021;15(1):9-17.

Keywords

palliative care
cause of death
population
cost-benefits analysis
models

Authors

Emilio Herrera Molina
Yaneth Marcela Montoya Jaramillo
Zacarías Rodriguez Álvarez-Ossorio
Ana Carolina Gñomez García
Miguel Ángel Lucas Díaz
Irma María Echeverri Rincón
Ingrid Muñoz Mayorga
María Nabal Vicuña

References (29)
  1. World Health Organization. Projections of mortality and causes of death, 2015 and 2030. Geneva 2015.
  2. Aldridge MD, Kelley AS. The Myth Regarding the High Cost of End-of-Life Care. Am J Public Health. 2015; 105(12): 2411–2415.
  3. Martos F, Herrera E, Espín J, et al. Socioeconomic implications. In: Jadad AR, Cabrera A, Smith R, Lyons RF. editors). When people live with multiple chronic diseases: a collaborative aroach to an emerging global challenge. Granada: Andalusian School of Public Health. 2010: 211–227.
  4. Franks PJ, Salisbury C, Bosanquet N, et al. The level of need for palliative care: a systematic review of the literature. Palliat Med. 2000; 14(2): 93–104.
  5. Congress of the republic. Consuelo Devis Saavedra Law; Official Gazette No. 49, 268. September 8, 2014. Constitutional Court. Law 1733 of 2014. Bogot 2014.
  6. Recommendation Rec 24 of the Committee of Ministers of the member states on palliative care organization. Madrid: Quality Agency of the National Health System. Ministry of Health. 2003; 2005.
  7. Schmidlin E, Oliver D. Palliative care as a human right: What has the Prague Charter achieved? Eur J Palliat Care. 2015; 22(3): 141–143.
  8. World Health Organization. Palliative care: Key facts. http://www.who.int/mediacentre/factsheets/fs402/es/ (9 September 2019).
  9. The 2015 Quality of Death Index: Ranking palliative care across the world. The Economist Inteligence Unit Limited 2015. https://eiuperspectives.economist.com/sites/default/files/2015%20EIU%20Quality%20of%20Death%20Index%20Oct%2029%20FINAL.pdf/ (25 August 2019).
  10. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage. 2006; 31(1): 58–69.
  11. Khandelwal N, Curtis JR, Freedman VA, et al. How Often Is End-of-Life Care in the United States Inconsistent with Patients' Goals of Care? J Palliat Med. 2017; 20(12): 1400–1404.
  12. Hudson PL, Aranda S, Kristjanson LJ. Meeting the supportive needs of family caregivers in palliative care: challenges for health professionals. J Palliat Med. 2004; 7(1): 19–25.
  13. Chastek B, Harley C, Kallich J, et al. Health care costs for patients with cancer at the end of life. J Oncol Pract. 2012; 8(6): 75s–80s.
  14. Committee on Approaching Death: Addressing Key End of Life Issues; Institute of Medicine. Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life. Washington (DC): National Academies Press (US); 2015 Mar 19. Appendix E, Epidemiology of Serious Illness and High Utilization of Health Care. https://www.ncbi.nlm.nih.gov/books/NBK285684/ (20 August 2019).
  15. Meier DE. Increased access to palliative care and hospice services: opportunities to improve value in health care. Milbank Q. 2011; 89(3): 343–380.
  16. May P, Garrido MM, Cassel JB, et al. Palliative Care Teams' Cost-Saving Effect Is Larger For Cancer Patients With Higher Numbers Of Comorbidities. Health Aff (Millwood). 2016; 35(1): 44–53.
  17. Nuño-Solinís R, Herrera Molina E, Librada Flores S, et al. [Care costs and activity in the last three months of life of cancer patients who died in the Basque Country (Spain)]. Gac Sanit. 2017; 31(6): 524–530.
  18. Librada S, Herrera E, Nuño R. Consumption of health resources and costs of end–of–life care for 18, 024 people killed by cancer in the Basque Country between 2008 and 2011. X Congress of the Spanish Palliative Care Society, Madrid 2014.
  19. Bekelman JE, Halpern SD, Blankart CR, et al. International Consortium for End-of-Life Research (ICELR). Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries. JAMA. 2016; 315(3): 272–283.
  20. Librada S, Herrera E, Nabal M. et al. Implementation models of cities and compassionate communities around people with advanced diseases and/or end of life situations: a systematic review. PROSPERO 2017: CRD42017068501. https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42017068501/ (24 July 2019).
  21. Librada S, Herrera E, Pastrana T. Attention centered on the person at the end of life: Integrated socio–health care in palliative care. Actas de la coordinación sociosanitaria. 2015; 13: 67.
  22. Tanuseputro P, Wodchis WP, Fowler R, et al. The health care cost of dying: a population-based retrospective cohort study of the last year of life in Ontario, Canada. PLoS One. 2015; 10(3): e0121759.
  23. Herrera E, Librada S, Lucas MA, et al. The New Health Foundation: Transforming palliative care. Eur J Palliat Care. 2017; 24(3).
  24. McNamara B, Rosenwax LK, Holman CD. A method for defining and estimating the palliative care population. J Pain Symptom Manage. 2006; 32(1): 5–12.
  25. National Administrative Department of Statistics. Technical bulletin Vital statistics (births, non-fetal deaths and fetal deaths). https://www.dane.gov.co/files/investigaciones/poblacion/bt_estadisticasvitales_2015pre-2016pre-diciembre-2016.pdf (20 October 2017).
  26. Montoya JY, Yepes M, Navales E, et al. 46.6 Million dollars a year in the last year of life: the opportunity to incorporate palliative care for 1, 8M of members of the health system in Colombia. X Congress of the Spanish Palliative Care Society. Madrid. 2014.
  27. Cheung MC, Earle CC, Rangrej J, et al. Impact of aggressive management and palliative care on cancer costs in the final month of life. Cancer. 2015; 121(18): 3307–3315.
  28. Brick A, Normand C. O'Hara S, Economic Evaluation of Palliative Care in Ireland, Trinity College, Dublin. Report prepared for The Atlantic Philanthropies, 2015 .
  29. Hugh T, Craft A, Davies C, et al. Funding the right care and support for everyone. Creating a fair and transparent funding system: the final report of the palliative care funding review. The Palliative Care Funding Review. 2011.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl